Disruptor Profile: Day Zero Diagnostics, Inc.

Day Zero Diagnostics Inc. is a medical technology company, which is developing a new class of diagnostics, including whole genome sequencing-based diagnostics, for modernizing the diagnosis and treatment of infectious disease using genome sequencing and machine learning (ML) technologies.


The report provides information and insights into Day Zero Diagnostics, Inc.'s, including –

– Overview of the company and its product offering

– Detailed insight into its business model, company type and headquarter

– Information on funding

– Biography of top management

Reasons to buy

– Gain insights into Day Zero Diagnostics Inc.’s business operations.

– Gain insights into fundings

– Gain understanding about its technology focus.

Companies mentioned

Sands Capital Ventures LLC

Golden Seeds LLC

TriVentures L.P.

National Institute of Allergies

Infectious Disease (NIAID)

Table of Contents

Table of contents

Company Overview

Technology Focus

Product Overview


Key Employees



Discounts available for multiple report purchases.

+44 (0) 161 359 5813

Join our mailing list

Saved reports